Commonwealth of Pennsylvania Public School Employees Retirement System’s ADMA Biologics ADMA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$460K Sell
54,961
-3,895
-7% -$35.5K ﹤0.01% 1439
2026
Q1
$530K Sell
58,856
-64
-0.1% -$1.01K ﹤0.01% 1376
2025
Q4
$1.07M Sell
58,920
-1,853
-3% -$31.2K 0.01% 1084
2025
Q3
$891K Sell
60,773
-520
-0.8% -$8.91K ﹤0.01% 1158
2025
Q2
$1.12M Buy
61,293
+4,723
+8% +$96.3K 0.01% 1024
2025
Q1
$1.12M Buy
56,570
+6,104
+12% +$106K 0.01% 974
2024
Q4
$865K Buy
50,466
+645
+1% +$12.1K 0.01% 1053
2024
Q3
$996K Buy
+49,821
New +$775K 0.01% 987

Other funds holding ADMA

Commonwealth of Pennsylvania Public School Employees Retirement System's ADMA Position: Q2 2026 in Review

Commonwealth of Pennsylvania Public School Employees Retirement System reduced its ADMA Biologics (ADMA) stake by 6.6% in Q2 2026, selling an estimated $35.5K and leaving 54,961 shares worth $460K. The position accounts for ﹤0.01% of the portfolio, ranked #1439.

Commonwealth of Pennsylvania Public School Employees Retirement System first reported a position in ADMA in Q3 2024 and has held it in 8 quarters since. The position peaked at $1.12M in Q1 2025. 159 funds tracked by Wall St. Rank hold ADMA as of Q2 2026.

  • Commonwealth of Pennsylvania Public School Employees Retirement System held 54,961 shares of ADMA Biologics worth $460K as of Q2 2026.
  • Commonwealth of Pennsylvania Public School Employees Retirement System sold 3,895 ADMA Biologics shares in Q2 2026, an estimated $35.5K.
  • ADMA Biologics made up ﹤0.01% of Commonwealth of Pennsylvania Public School Employees Retirement System's portfolio in Q2 2026, its #1439 holding.
  • Commonwealth of Pennsylvania Public School Employees Retirement System first reported a position in ADMA Biologics in Q3 2024 and has held it in 8 quarters since.
  • Commonwealth of Pennsylvania Public School Employees Retirement System's ADMA Biologics position peaked at $1.12M in Q1 2025.
  • 159 funds tracked by Wall St. Rank held ADMA Biologics as of Q2 2026.

Based on Commonwealth of Pennsylvania Public School Employees Retirement System's 13F filing for Q2 2026, filed 17 Jul 2026.